| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.06B | — | +4.9% |
| Cost of Revenue | $3.15B | — | -9.6% |
| Gross Profit | $2.91B | — | +27.1% |
| R&D Expense | $1.04B | — | +36.6% |
| SG&A Expense | $857.6M | — | +74.4% |
| Operating Income | -$172.0M | — | -152.2% |
| Pre-tax Income | -$392.6M | — | -272.9% |
| Income Tax | -$84.0M | — | -319.1% |
| Net Income | -$308.7M | — | -262.6% |
| EPS (Basic) | -$0.52 | — | -267.7% |
| EPS (Diluted) | -$0.52 | — | -273.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.86B | +4.5% | -3.3% |
| Accounts Receivable | $242.5M | +1.8% | +45.3% |
| Inventory | $174.3M | +10.1% | +60.2% |
| Current Assets | $23.77B | +4.0% | +20.6% |
| Total Assets | $39.99B | +1.1% | +9.9% |
| Current Liabilities | $11.97B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $965.6M | — | +624.2% |
| Capital Expenditures | $30.6M | — | -4.1% |
| Investing Cash Flow | $300.0M | — | -67.2% |
| Financing Cash Flow | -$251.9M | — | +79.2% |
| Free Cash Flow | $935.0M | — | +821.6% |
| +37.8% |
| Long-term Debt | $7.29B | +0.0% | +42.8% |
| Total Liabilities | $18.31B | +5.3% | +22.4% |
| Stockholders' Equity | $21.72B | -2.2% | +1.1% |